Ligand binding assays
Accelerating biologics development with proven expertise
Ligand binding assays (LBAs) are essential for measuring biotherapeutics, biomarkers, and immune responses. We provide assay development, validation, and sample analysis services supporting programs from preclinical research through post-market surveillance.
Our ligand binding assay capabilities
We support a broad range of ligand binding applications, including:
-
Pharmacokinetic (PK) testing
-
Anti-drug antibody (ADA) testing
-
Immunogenicity assessments
-
Biomarker analysis
-
Pharmacodynamic (PD) assays
-
Neutralizing antibody assays
-
Protein and peptide quantification
-
Cytokine and soluble marker analysis
-
Multiplex immunoassays
Our team develops and validates assays using established and emerging technologies to meet the specific needs of each program.
Supporting biologics and advanced therapeutics
We have experience supporting diverse therapeutic modalities, including:
-
Monoclonal antibodies
-
Bispecific antibodies
-
Antibody-drug conjugates (ADCs)
-
Recombinant proteins
-
Peptides
-
Cell and gene therapy programs
-
Novel biologic platforms
From early feasibility assessments through late-stage clinical studies, we provide the scientific expertise needed to navigate complex bioanalytical challenges.
Why partner with us?
Scientific expertise
Our experienced bioanalytical scientists collaborate with sponsors to develop tailored assay strategies that align with study objectives, therapeutic mechanisms, and regulatory requirements.
Fit-for-purpose solutions
Our experienced bioanalytical scientists collaborate with sponsors to develop tailored assay strategies that align with study objectives, therapeutic mechanisms, and regulatory requirements.
Flexible support across the development lifecycle
Whether you need a single assay or comprehensive bioanalytical support, we provide scalable solutions that evolve with your program from discovery through commercialization.
High-quality data
Reliable data is essential for confident decision-making. Our rigorous analytical processes and quality systems help ensure data integrity throughout every phase of development.
Ligand binding assays for clinical development
As biologics become increasingly complex, the need for sensitive, reproducible, and scientifically sound ligand binding assays continues to grow. Our team helps sponsors generate the bioanalytical data needed to evaluate safety, efficacy, immunogenicity, and therapeutic performance across all phases of development.
Webinar
Matrix Interference in Ligand-Binding Assays: Modern Solutions to an Established Analytical Problem
Strategies to overcome matrix interference in ligand-binding assays for accurate results.
Blog
Unlocking Precision: The Power of Ligand Binding Assays in Clinical Trials
Learn how ligand binding assays (LBAs) provide precise, compliant analysis for biologics in clinical trials, supported by Eurofins’ expert bioanalytical services.
Webinar
Considerations for Ligand Binding Assay Platforms: How to Choose the Right Platform to Meet Your Drug Development Needs
Tips for selecting the right assay platform to meet drug development needs.
Ready to advance your biologics program?
